Journal Information
Visits
23
Original article
Full text access
Available online 4 June 2025
Dietary characteristics of Mexican patients with irritable bowel syndrome: Is there a distinction from the general population?
Características de la alimentación de los pacientes mexicanos con síndrome de intestino irritable. ¿Se distingue de la población general?
Visits
23
M. Amieva-Balmori, G.P. Martínez-Pérez
Corresponding author
genesismp12@gmail.com

Corresponding author at: Iturbide S/N Col. Centro, C.P 91700, Mexico. Tel.: +52 2291076294.
, M.R. Francisco, A. Triana-Romero, A.A. Ortiz-Lorenzo, G.A. Hernández-Ramírez, J.A. Martínez-Conejo, G.A. Violante-Hernández, A.D. Cano-Contreras, J.M. Remes-Troche
Instituto de Investigaciones Médico-Biológicas, Universidad Veracruzana, Xalapa, Veracruz, Mexico
This item has received
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Figures (3)
Show moreShow less
Tables (5)
Table 1. Sociodemographic variables of the population studied.
Tables
Table 2. Calorie, fat, and macronutrient intake of healthy controls and IBS patients.
Tables
Table 3. Vitamin and mineral intake of healthy controls and IBS patients.
Tables
Table 4. Intake of healthy controls and IBS patients by sex.
Tables
Table 5. Macronutrient and micronutrient intake by IBS subtype.
Tables
Show moreShow less
Abstract
Introduction

Irritable bowel syndrome (IBS) is a multifactorial condition, in which diet is a main trigger of symptoms. Many patients modify their diet without professional supervision, which can cause nutritional risks or aggravate symptoms. The aim of this study was to evaluate the dietary intake of patients with IBS versus healthy subjects.

Material and methods

An observational, analytic, cross-sectional study was conducted on 108 subjects: 77 (71.3%) diagnosed with IBS (Rome IV criteria) and 31 (28.7%) healthy controls. Patient age was from 18 to 66 years and the woman-to-man ratio was 4.1:1. Both groups completed a 7-day food diary, registering their usual diet that was then analyzed using a nutrition software program.

Results

Macronutrient intake was similar between the two groups but the patients with IBS had a significantly higher intake of vitamins D (p ≤ 0.001), B1 (p ≤ 0.001), B2 (p ≤ 0.001), and B3 (p ≤ 0.001). There was greater vitamin B3 intake in patients with an IBS subtype (p = 0.005). There were no significant differences in fiber consumption.

Conclusion

The diet of Mexican patients with IBS was slightly different from that of healthy subjects. The IBS patients consumed more fiber and their FODMAP intake was similar to that of the healthy controls. Even though the majority of the IBS patients met the recommendations for macronutrient and micronutrient intake, nutritional guidance in the management of IBS is recommended because dietary adjustments can significantly improve symptoms.

Keywords:
Irritable bowel syndrome
Diet
Macronutrients
Micronutrients
Resumen
Introducción

El síndrome de intestino irritable (SII) es una condición multifactorial, donde la dieta es un desencadenante principal de los síntomas. Muchos pacientes modifican su alimentación sin supervisión profesional, lo que puede ocasionar riesgos nutricionales o agravar los síntomas. El objetivo de este estudio fue evaluar la ingesta dietética de pacientes con SII comparado con sujetos sanos.

Material y métodos

Estudio transversal, analítico y observacional con 108 sujetos: 77 (71.3%) con diagnóstico de SII (criterios Roma IV) y 31 (28.7%) controles sanos, con edades entre 18 y 66 años y una proporción de 4.1:1 entre mujeres y hombres. Ambos grupos completaron un diario alimentario de 7 días, registrando su dieta habitual, analizada mediante un programa de nutrición.

Resultados

La ingesta de macronutrientes fue similar entre los grupos. Sin embargo, los pacientes con SII mostraron un consumo significativamente mayor de vitaminas D (p ≤ 0.001), B1 (p ≤ 0.001), B2 (p ≤ 0.001) y B3 (p ≤ 0.001). Entre los subtipos de SII, se observó un mayor consumo de vitamina B3 (p = 0.005). No hubo diferencias significativas en el consumo de fibra.

Conclusión

La dieta de los pacientes mexicanos con SII presenta leves diferencias respecto a los sujetos sanos. Los pacientes con SII consumen más fibra y tienen una ingesta de FODMAPs similar a los controles sanos. Aunque la mayoría de estos pacientes cumple con la ingesta recomendada de macro y micronutrientes, se recomienda orientación nutricional en el manejo del SII, ya que los ajustes dietéticos pueden mejorar significativamente los síntomas.

Palabras clave:
Síndrome de intestino irritable
Dieta
Macronutrientes
Micronutrientes
Full Text
Introduction

Irritable bowel syndrome (IBS) belongs to the group of conditions known as disorders of gut-brain interaction, previously called functional gastrointestinal disorders.1 In Mexico, the prevalence of IBS varies from 16 to 35% and the worldwide prevalence is 11%. It predominates in females and greatly affects patient quality of life.2–4 IBS is characterized by the presence of pain or intestinal discomfort associated with changes in bowel habits, in the absence of an organic lesion causing the symptoms.5

IBS pathophysiology is complex and multifactorial. Gut microbiota alterations, psychologic comorbidity (anxiety, depression), visceral hypersensitivity, bile acid malabsorption, increased intestinal permeability, and dietary factors are among the main factors described.6 The role of diet has garnered special interest in recent years, regarding the pathogenesis of IBS.7 Up to two-thirds of subjects with IBS are reported to perceive that their symptoms are related to a dietary component, and so they restrict or eliminate certain foods from their diet that they consider triggers, without the evaluation of a nutritional expert.8 Milk and its derivatives, wheat, caffeine, meats, cabbage, onions, legumes, chili peppers, fried foods, and smoked products are among the foods most commonly identified as culprits, which when restricted, could condition the risk of imbalanced nutrition.8,9

There are numerous intervention studies on patients with IBS that eliminate the foods most commonly identified as triggers (FODMAPs), but few studies describe the characteristics of the usual diet of said patients. Therefore, the aim of our study was to evaluate the dietary composition in Mexican IBS patients and compare it with that of healthy subjects.

Methods

An observational, analytic, cross-sectional study was conducted at the Instituto de Investigaciones Médico-Biológicas of the Universidad Veracruzana within the time frame of January to June 2022.

Subjects

Patients referred to our center that were above 18 years of age and diagnosed with IBS, based on the Rome IV criteria,10 were included in the study. A group of subjects considered asymptomatic, in the absence of Rome IV criteria, and that presented with no previous diseases were the healthy controls. They were selected from an open population as voluntary participants, giving their authorized informed consent. Subjects with serious diseases that could affect nutrient intake were excluded from the study and subjects that did not complete the 7-day food diary were eliminated from it (Fig. 1).

Figure 1.

Flow diagram showing the participant selection process.

Source: This figure is original and authored by me.

(0.11MB).
Food diary

Both groups received a diary designed to register food consumption for a period of 7 days. The subjects were told to maintain their usual diet and record all foods and drinks consumed daily, describing the quantities as accurately as possible. Special emphasis was placed on writing a detailed description of the ingredients in each food that was recorded. To make a uniform quantity calculation easier, a guide on food portion sizes with photographs was provided.

After completing the 7-day food diary, the information was entered into the Nutrimind® software program, which is specially designed to provide a detailed analysis of dietary intake, based on the Mexican System of Food Equivalents,11 registering the type of food, ingredients, and beverages consumed. From those data, Nutrimind® calculates the daily intake of macronutrients, micronutrients, and calories for each individual. The weekly average of dietary intake is then calculated for each patient. Importantly, the data obtained were corroborated by a nutrition specialist. In addition, FODMAP intake was evaluated utilizing the Monash University traffic light system,12 which categorizes foods in relation to their high or low FODMAP content.

Statistical analysis

Data distribution was assessed through the Kolmogorov-Smirnov test and homoscedasticity through the Levene’s test. The numerical variables were expressed as mean and standard deviation or interquartile range and compared using the Student’s t test or the Mann-Whitney U test, as appropriate. The categorical variables were presented as frequencies and percentages and compared using the chi-square test or the Fisher’s exact test. Comparisons between the two groups were made through the ANOVA test or Kruskal-Wallis test, as appropriate. Statistical significance was set at a p value < 0.05. The analysis of the results was carried out using the SPSS® version 26 program.

Ethical considerations

This study was conducted according to the Declaration of Helsinki and was approved by the local research committee of the Instituto de Investigaciones Médico-Biológicas. All the subjects authorized their participation through informed consent.

Results

A total of 108 subjects were included in the study. The mean age of the participants was 26 years, with a range of 18-66 years. Seventy-seven (71.3%) of the participants met the Rome IV criteria10 for the diagnosis of IBS, with a median age of 26 years (24-46.5) and a predominance of females (85.7%). Thirty-one (28.7%) of the subjects were classified as healthy, their mean age was 25 years (20-31.25), and 67.3% were females. The patients with IBS had greater overweight, with a BMI of 26.07 (± 4.5), compared with the 23.6 (± 3.0) for the healthy controls (p = 0.007) (Table 1).

Table 1.

Sociodemographic variables of the population studied.

  Healthy controls  IBS patients  p value 
n (%)  31 (28.7%)  77 (71.3%)   
Ageb  25 (20-31.25)  26 (24-46.5)  0.001 
Sex F/M  21 (67.7%) / 10 (32.3%)  66 (85.7%) / 11 (14.3%)  0.033 
BMIa  23.61 ± 3.0  26.07 ± 4.52  0.002 

BMI: body mass index; F: female; IBS: irritable bowel syndrome; IQR: interquartile range; M: male; SD: standard deviation.

a

Normal distribution (mean ± SD).

b

Non-normal distribution (median-IQR).

The subtype distribution was diarrhea-predominant IBS (IBS-D) in 21 (19.4%) patients, constipation-predominant IBS (IBS-C) in 33 (30.6%), and mixed-type IBS (IBS-M) in 23 (21.3%).

Calories, fats, and macronutrients

IBS patients had a higher caloric intake, with a mean 1,971.84 ± 641.03 kcal, compared with the healthy subjects, who registered a mean 1,812.5 ± 567.44 kcal, and total fat intake was lower in the IBS patients. The differences were not statistically significant.

With respect to macronutrients, there were no statistically significant differences between the two groups. The patients with IBS had a slightly lower fiber intake, with a mean 18.6 ± 7.2 g, compared with the healthy subjects, who had a mean 16.8 ± 5.5 g, but that difference was not statistically significant (Table 2).

Table 2.

Calorie, fat, and macronutrient intake of healthy controls and IBS patients.

Healthy controls  IBS patients  p value
n = 31  n = 77 
Caloriesa  1,812.5 ± 567.44  1,971.84 ± 641.03  0.231 
Total fats (g)b  80.14 (50.71-89.57)  78.43 (58.45-98.5)  0.209 
Saturated fats (g)b  17.14 (12.71-22)  17.57 (12.29-24.21)  0.422 
Monounsaturated fats (g)b  18.29 (13-22.43)  23.14 (15.07-31.78)  0.118 
Polyunsaturated fats (g)b  6.29 (4.86-8.86)  10 (6-12.85)  0.948 
Proteins (g)a  87.6 ± 27.0  86.78. ± 24.39  0.869 
Carbohydrates (g)a  196.2 ± 65.5  212.8 ± 63.5  0.229 
Fiber (g)a  16.8 ± 5.5  18.6 ± 7.2  0.210 
Sugars (g)b  40.14 (32.57-55.57)  38 (30.35-55.87)  0.560 

g: grams; IBS: irritable bowel syndrome; IQR: interquartile range; SD: standard deviation.

a

Normal distribution (mean ± SD).

b

Non-normal distribution (median-IQR).

Micronutrients (vitamins and minerals)

The IBS patients had a significantly higher intake of vitamin D (105.71 [59.78-155.95] vs 2.29 [1.29-3.29], p ≤ 0.001); thiamin B1 (2 [1.07-18.5] vs 1 [0.57-1.29], p ≤ 0.001); riboflavin B2 (3 [1.28-35.21] vs 1.43 [0.86-1.71], p ≤ 0.001); and niacin B3 (33.57 [17.15-1433.43] vs 14.14 [11.14-18.71], p ≤ 0.001), compared with the healthy subjects. Mineral intake was not statistically significant, with similar values in the two groups (Table 3).

Table 3.

Vitamin and mineral intake of healthy controls and IBS patients.

Healthy controls  IBS patients  p value
n = 31  n = 77 
Vitamin A (mcg)b  376 (301.71-511.29)  437(311.36-714.84)  0.173 
Vitamin D (mcg)b  2.29 (1.29-3.29)  105.71 (59.78-155.95)  <0.001 
Vitamin E (mcg)b  3.43 (2.57-3.43)  4.71 (2.95-6.93)  0.066 
Vitamin C (mg)b  67.86 (42-102.71)  82.71 (53.29-116.14)  0.158 
Thiamin B1 (mg)b  1 (0.57-1.29)  2 (1.07-18.5)  <0.001 
Riboflavin B2 (mg)b  1.43 (0.86-1.71)  3 (1.28-35.21)  <0.001 
Niacin B3 (mg)b  14.14 (11.14-18.71)  33.57 (17.15-1433.43)  <0.001 
Pyridoxin B6 (mcg)b  1.14 (0.86-1.29)  1.30 (1-1.86)  0.449 
Folate B9 (mcg)b  290.29 (207.71-390.14)  328.86 (247.92-516.71)  0.114 
Cobalamin B12 (mcg)b  3.14 (2-4.57)  3.4 (2.07-4.71)  0.319 
Sodium (mg)a  2009.1 ± 667  1942.49 ± 835.87  0.693 
Potassium (mg)a  1907.32 ± 539.64  2021.48 ± 669.03  0.400 
Calcium (mg)a  1003.8 ± 361.86  909.95 ± 358.6  0.222 
Magnesium (mg)b  221.71 (181.29-275.71)  242.71(181.57-310.66)  0.256 
Phosphorus (mg)a  955.6 ± 312.9  1038.07 ± 308.37  0.214 
Iron (mg)b  14.43 (11.14-18.29)  14.71 (11.78-20.07)  0.496 
Zinc (mg)b  8.57 (5.71-14.14)  9.57 (7.21-13.93)  0.241 
Selenium (mcg)b  68.71 (54-80.57)  72.86 (54.14-94.21)  0.527 
Iodine (mcg)a  153.22 ± 50.73  147.17 ± 62.9  0.635 

IBS: irritable bowel syndrome; IQR: interquartile range; mcg: micrograms; mg: milligrams; SD: standard deviation.

a

Normal distribution (mean ± SD).

b

Non-normal distribution (median-IQR).

Upon determining energy (calories) and the macronutrients, adjusted according to the calculated ideal weight of each subject, and analyzing the micronutrient intake, considering the daily recommended levels for the Mexican population that vary according to age and sex,13,14 more than half of the subjects with IBS did not meet the intake recommendations. This was particularly noticeable in fiber consumption, as well as in minerals, such as zinc, magnesium, iron, potassium, and calcium, and in vitamins A, E, B9, and D (Fig. 2).

Figure 2.

Percentage per subject group that met and did not meet the recommended calorie, macronutrient, and micronutrient intake. Recommended macronutrient intake was determined according to ideal weight of each subject and micronutrient intake by age and sex.

IBS: irritable bowel syndrome.

Source: Nutrient intake recommendations for the Mexican population.12,13

(0.52MB).

In the sub-analysis by sex, males had a higher caloric intake than females. Males in the IBS group had a significantly higher caloric intake (p = 0.046) and a higher intake of total fats (p = 0.024), polyunsaturated fats (p = 0.011), proteins (p = 0.003), sodium (p = 0.001), calcium (p = 0.025), and phosphorus (p = 0.034). In contrast, the male healthy controls had a significantly higher intake of monounsaturated fats (p = 0.017), thiamin (p = 0.028), cobalamin (p = 0.035), and selenium (p = 0.021). Vitamin C was the exception, as its intake was higher in females (p = 0.038) (Table 4).

Table 4.

Intake of healthy controls and IBS patients by sex.

Healthy controls  p valueIBS patients  p value
F/M  F/M 
Caloriesa  1688.5 ± 510.2 / 2072.98 ± 619.3  0.077  1912.6 ± 629.8 /2327 ± 618.3  0.046 
Total fats (g)b  61.5 (48.7-87.8) /85.5 (78.3-96.2)  0.095  76.21 (56-91.4) /112.71 (89.6-124.4)  0.024 
Saturated fats (g)b  15.14 (12.1-21.1) /19.35 (15.5-23.6)  0.197  16.71 (11.9-20.9) /26.28 (16.7-36.7)  0.260 
Monounsaturated fats (g)b  14.43 (12.2-20.5) /22.57 (16.1-27.8)  0.017  20.92 (14.3-27.4) /31.86 (23.6-49)  0.207 
Polyunsaturated fats (g)b  5.43 (4.1-7.5) /22.57 (16.1-27.8)  0.990  8.42 (5.8-12.3) / 13 (8.5-49)  0.011 
Proteins (g)a  82.4 ± 19.6 / 98.6 ± 37.1  0.220  83.42 ± 22.78 / 106.89 ± 25  0.003 
Carbohydrates (g)a  181.4 ± 58.5 / 227.5 ± 71.5  0.393  208.4 ± 61.3 / 239.1 ± 72.9  0.139 
Fiber (g)a  17 ± 5.7 / 16.28 ± 5.5  0.729  18.7 ± 7.1 / 18.1 ± 7.7  0.807 
Sugars (g)b  40.1(30-53.6) /41(32.8-57.6)  0.858  37.78(29.4-55.7) /46.29 (32.8-65.7)  0.989 
Vitamin A (mcg)b  339.5 (301.2-495.7) /415 (295.5-558.6)  0.773  435.78(279.6-756.2) /486.85(373.2-581.1)  0.925 
Vitamin D (mcg)b  2.29 (1.1-3.1) /2.7 (1.8-4)  0.183  105 (60.1-155.7) / 110.3 (55.7-216.7)  0.610 
Vitamin E (mcg)b  3.43 (2.5-4.78) / 3.8(2.7-6.4)  0.651  4.43 (2.8-6.8) /6.71 (5.3-7.4)  0.611 
Vitamin C (mg)b  75.14 (55.2-116.9) /42.9 (29.8-72.7)  0.038  83.64 (51.5-118.9) /82.7 (56.2-100.2)  0.727 
Thiamin B1 (mg)b  0.86 (0.57-1.1) /1.3 (0.99-1.6)  0.028  2 (1-18.8) / 1.86 (1.1-5.1)  0.624 
Riboflavin B2 (mg)b  1.29 (0.86-1.6) /1.5 (1.2-1.9)  0.133  3.57 (1.18-36.6) / 1.86(1.4-8.5)  0.541 
Niacin B3 (mg)b  13.4 (10.3-15.9) / 18.7 (12.4-24)  0.136  34.21 (15.1-1453.1) / 25.43 (20-51.8)  0.902 
Pyridoxine B6 (mcg)b  1.14 (0.86-1.2) / 1.29 (0.96-1.9)  0.119  1.29 (1-1.86) / 1.71 (1.1-1.9)  0.670 
Folate B9 (mcg)b  258.5 (179.2-385) /310.4 (225.4-503.5)  0.495  324.28 (245.4-496.3) / 336.29 (252.7-525.4)  0.658 
Cobalamin B12 (mcg)b  2.43 (1.6-4.3) /3.57 (3-5.9)  0.035  3.1 (2-4.71) / 3.85 (2.4-7.1)  0.230 
Sodium (mg)a  1933.8 ± 631/2167.3 ± 748.2  0.372  1821.7 ± 679.4 /2666.7 ± 1279.1  0.001 
Potassium (mg)a  1877.4 ± 568.94 / 1970 ± 494.9  0.663  2007.2 ± 667 /2106.6 ± 707.5  0.651 
Calcium (mg)a  952.05 ± 390.3/1112.7 ± 280  0.254  872.7 ± 335.9/1133 ± 424  0.025 
Magnesium (mg)b  221.71 (174.2-267.3) /207.9 (182.5-297.7)  0.594  240.57(174.5-304.2) /285.86(184.5-348.3)  0.140 
Phosphorus (mg)a  888.74 ± 245.9/1096.2 ± 399.44  0.084  1007.8 ± 300.6/1219.6 ± 305  0.034 
Iron (mg)b  14.43 (10.2-17.29) / 14.28 (12.5-21.9)  0.777  14 (11.21-18.2) /19.43 (13-22.29)  0.864 
Zinc (mg)b  8 (4.9-13.8) / 10.14 (6.9-15.4)  0.296  9.5 (7-14.32) /11.86 (8.1-13.2)  0.528 
Selenium (mcg)b  67.29 (53-70.2) /90.64 (51.6-119.1)  0.021  66.14 (52.3-83.5) / 101.28 (90-128.7)  0.693 
Iodine (mcg)a  147.5 ± 47.8/ 165.1 ± 57  0.376  137.8 ± 50.5/203.2 ± 97.4  0.052 

F: female; g: grams; IBS: irritable bowel syndrome; IQR: interquartile range; M: male; mcg: micrograms; mg: milligrams; SD: standard deviation.

a

Normal distribution (mean ± SD).

b

Non-normal distribution (median-IQR).

Irritable bowel syndrome subtypes

The analysis of macronutrient and micronutrient by IBS subtype showed no significant differences, except for vitamin B2 (p = 0.030) and vitamin B3 (p = 0.021), which were significantly higher in the patients with IBS-M (Table 5).

Table 5.

Macronutrient and micronutrient intake by IBS subtype.

IBS-D  IBS-C  IBS-M  p value
n = 21  n = 33  n = 23 
Proteins (g)a  88.18 ± 28.51  82.67 ± 26.0  91.39 ± 16.74  0.406 
Carbohydrates (g)a  216.8 ± 49.57  200.4 ± 59.1  226.86 ± 78.6  0.297 
Fiber (g)a  18.16 ± 7.1  18.03 ± 6.4  19.88 ± 8.34  0.610 
Sugars (g)b  35.29 (29.85-48.71)  43.36 (28.21-54.54)  39.86 (32-61.71)  0.310 
Vitamin A (mcg)b  417.29 (291.28-606.14)  507.3 (338.14-714.84)  434.57 (209.43-775.43)  0.611 
Vitamin D (mcg)b  85.86 (57-135.93)  121.57 (67.49-155.95)  104.29 (55.71-181.57)  0.470 
Vitamin E (mcg)b  5.57 (3.5-8.42)  4.4 (3-6.68)  4.43 (2.43-6.71)  0.312 
Vitamin C (mg)b  80.85 (53.93-93.78)  82 (55.35-113.92)  96.26 (46.29-161.14)  0.778 
Thiamin B1 (mg)b  1.86 (1-14.28)  1.6 (0.95-16.42)  6.43 (1.43-32)  0.053 
Riboflavin B2 (mg)b  1.71 (1.07-28.92)  1.71 (1.17-23.41)  26.71 (1.57-84)  0.030 
Niacin B3 (mg)b  34.85 (14.64-485.64)  23.43 (14.5-798.49)  52.14 (26.57-2565.86)  0.021 
Pyridoxine B6 (mcg)b  1.29 (0.93-1.86)  1.33 (1-1.88)  1.29 (1-2)  0.556 
Folate B9 (mcg)b  328.86 (212.28-444.43)  319.71 (253.14-542.85)  358.43 (247.14-525.43)  0.861 
Cobalamin B12 (mcg)b  3.71 (2.21-4.71)  3.4 (2-5)  3.14 (1.86-6.14)  0.977 
Sodium (mg)a  1939.2 ± 882.11  1825.3 ± 852.4  2113.5 ± 773.2  0.452 
Potassium (mg)a  1934.1 ± 591.3  1988.3 ± 670.9  2148.7 ± 740.1  0.536 
Calcium (mg)a  857.8 ± 250.36  869.1 ± 409.7  1016.1 ± 355.1  0.238 
Magnesium (mg)b  242.71 (171.36-321)  243.86 (183.78-306.59)  235.29 (180.14-321.86)  0.956 
Phosphorus (mg)a  1053.1 ± 335.7  990 ± 315  1093.2 ± 273.5  0.458 
Iron (mg)b  15 (11.92-21.21)  13.42 (10.64-17.95)  15.71 (12-20.86)  0.324 
Zinc (mg)b  11.86 (7.78-14.57)  9.6 (7.21-13.35)  8.71 (6.86-11.86)  0.429 
Selenium (mcg)b  72.86 (54.92-112.57)  71.86 (49.85-85.5)  75.86 (58-90)  0.512 
Iodine (mcg)a  145.4 ± 65.2  138.6 ± 64.4  161 ± 58.9  0.424 

g: grams; IBS-C: constipation predominant irritable bowel syndrome; IBS-D; diarrhea predominant irritable bowel syndrome; IBS-M: irritable bowel syndrome, mixed type; IQR: interquartile range; mcg: micrograms; mg: milligrams; SD: standard deviation.

a

Normal distribution (mean ± SD).

b

Non-normal distribution (median-IQR).

FODMAPs

The subjects with IBS consumed food with a high content of fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAPs). This was especially notable in products containing lactose (dairy products), galacto-oligosaccharides (legumes), and fructose (fruits). Relevantly, the consumption of those foods was similar to that of the healthy controls. IBS subjects consumed vegetables, cereals, and fats with a low FODMAP content more often. On the other hand, the healthy subjects had a higher intake of fructo-oligosaccharides (in cereals) and oils (Fig. 3).

Figure 3.

The FODMAP content “traffic light” per food group. Subjects with irritable bowel syndrome (IBS) had a higher intake of high-content FODMAPs in the dairy, legume, and fruit groups, whereas the healthy subjects had a higher intake of high-content FODMAPs in the dairy, legume, fruit, cereal, and oil groups.

Source: This figure is original and authored by me.

(0.11MB).
Discussion

Our results indicate there were subtle differences in dietary composition, between patients with IBS and healthy subjects. It is relevant that the caloric intake in IBS subjects was higher, partially explaining the overweight in that group. Even though that is not completely described in IBS, attention should be paid to underlying eating disorders.

Saito et al. found that patients with gastrointestinal disorders consumed more saturated and monounsaturated fats and relatively fewer carbohydrates.15 With respect to fat intake, the results were similar in our study, given that monounsaturated fat intake was higher in the IBS patients, albeit not statistically significant. The higher intake in those patients could be due to the fact that said fats are catalogued as healthy and found in foods, such as avocado, nuts, seeds, and olive oils, and are consumed in an effort to improve digestive health.16

The daily recommended intake of dietary fiber in the general population is 20-30 g, whether from natural sources or supplements.17 We found that the fiber intake of our study participants was below said recommendations. Only 25% of the subjects with IBS reached the recommended intake values but their mean fiber consumption was slightly higher, reaching 18.6 g, than that of the healthy subjects, at 16.8 g. However, the difference was not statistically significant.

Interestingly, in the subtype analysis, the patients with IBS-M had a higher fiber intake but the patients with IBS-C did not; despite their having the predominant symptom of constipation, those patients only consumed an average of 18 g per day.

With respect to micronutrients, Roth et al. evaluated dietary intake in 105 patients with IBS. They reported that micronutrient intake was below the recommendations, especially regarding iron and selenium.18 In addition, different studies have found inadequate intake of vitamins A, B2, B6, B9, and B12, as well as of calcium and zinc, in the usual diet of patients with IBS.19 Those findings are consistent with our results, which indicated that a considerable number of IBS patients had intakes of calcium, iron, magnesium, zinc, and vitamins A, D, E, and B9 below the daily recommendations. Nevertheless, compared with the healthy controls, the IBS patients had significantly higher intakes of vitamins D, B1, B2, and B3, and in the IBS subtype analysis, vitamin B3 was significantly higher in the IBS-M subtype. Those results could have been influenced by dietary modifications, such as the inclusion of healthy and enriched foods, such as whole-grain cereals or enriched vegetable alternatives, among others.20

Zhang et al. reported that elevated magnesium intake was inversely proportional to the presence of constipation, due to its osmotic laxative effect, given that it is incompletely absorbed in the gastrointestinal tract.21,22 However, in our results, magnesium intake was higher in the healthy controls, with no statistically significant difference. The importance of adequate vitamin and mineral intake lies in their participation in nutrient absorption, intestinal motility, and gut microbiota modulation, among other essential physiologic processes.23

Böhn L et al. conducted a comparative study on the nutrient intake of subjects with IBS and the general population, through a 4-day food diary. The dietary components were very similar, but there was a greater intake of vitamin E, folate, iron, and vitamin C and a lower intake of vitamin A, riboflavin, calcium, and potassium, in the IBS subjects. They concluded that the differences in nutrient intake indicated a tendency toward a higher consumption of fruits and vegetables and a lower consumption of meats and dairy products in patients with IBS.24 Given the above, it has been established that when eliminating a specific food, its replacement is sought in accordance with its nutritional content, to prevent nutritional deficiency in those patients.8

In the study carried out by Torres MJ et al. in France, those authors collected the dietary data of 36,448 individuals, each of them with at least 3 self-administered 24 h registers. The results indicated that the patients diagnosed with IBS presented with a higher total caloric intake, concurring with our study findings. In addition, they identified significant differences in monounsaturated fat intake, which was increased in the IBS patients. However, in contrast with our study results, they described a higher consumption of fiber in the healthy subjects of their analysis. Likewise, calcium, potassium, zinc, and vitamin B2, B5, and B9 intake was significantly lower in the patients with IBS, compared with the healthy controls.25 It should be pointed out that even though calcium intake results were not statistically significant in our findings, there was a decrease in the IBS patients, compared with the healthy subjects, with 25% of the patients meeting the daily intake recommendations. This could be attributed to the fact that the IBS patients reported greater intolerance to dairy products that could be associated as symptom triggers. Therefore, when evaluating IBS patients, risk factors for osteopenia should be contemplated. 26

FODMAP-rich foods represent a wide variety of dietary compounds that are present in the human diet, encompassing the categories that include fruits, vegetables, legumes, cereals, bee products, dairy products, and sweeteners. The mean daily FODMAP intake in a conventional diet is estimated at 15 to 30 g.27 According to the classification adopted by Monash University, dairy products, especially cow’s milk, yogurt, and ice cream, are foods with a high FODMAP content. Practically all legumes, especially beans, fall into that same category, as do apples, watermelon, pears, and mangoes, in the fruit group.28 Pertinently, many of those foods are easily accessible and very common in the Mexican diet.

Even though IBS is more prevalent in women, a meta-analysis that examined the impact of diet on its prevalence found no significant correlation between dietary intake and the prevalence of IBS, in relation to sex.29 Nevertheless, the slight differences seen in the dietary changes between men and women could suggest a true behavioral variation, with respect to the predisposition to modify or report their dietary patterns.30

One of the limitations of our study was its reduced sample size, which impeded a detailed evaluation of the macronutrient and micronutrient intake in different age groups. Another was the use of the Nutrimind® program, which despite having been developed in Mexico, did not include typical regional ingredients in its catalogue, forcing us to employ equivalents that might not exactly reflect the usual diet of the population studied. The daily food registering and monitoring for the study could also have had an individual impact on the quantity and frequency of certain foods. In addition, we had no information on the presence or severity of symptoms in the IBS patients, nor did we have information on whether they had previously modified their dietary intake, to reduce symptoms or for some other reason.

Conclusion

In conclusion, the diet of patients with IBS was comparable to that of the healthy controls and did not negatively affect nutrient intake. The majority of the diets met the daily macronutrient and micronutrient recommendations for the Mexican population. Notably, in our population with IBS, FODMAP consumption was high, and fiber intake was low, despite the prevalence of IBS-C. Therefore, adopting a personalized nutritional focus in the initial evaluation of IBS patients is essential. Dietary adjustments can significantly contribute to general improvement, treatment efficacy, and as a consequence, improved quality of life, an aspect that is often deteriorated in IBS patients.

Financial disclosure

No financial support was received in relation to this study/article.

References
[1]
R.W. Otero, P.L. Otero, F.H. Marulanda.
Síndrome de intestino irritable (SII): Nuevos conceptos en 2023.
Medicina, 44 (2022), pp. 347-371
[2]
M.A. Adeyemo, B.M.R. Spiegel, L. Chang.
Meta-analysis: do irritable bowel syndrome symptoms vary between men and women?.
Aliment Pharmacol Ther, 32 (2010), pp. 738
[3]
A. Rej, A. Avery, I. Aziz, et al.
Diet and irritable bowel syndrome: an update from a UK consensus meeting.
[4]
J. Remes-Troche.
Síndrome de Intestino Irritable: de la fisiopatología al tratamiento.
X Gastrotrilogía, 1 (2017), pp. 141-151
[5]
R. Carmona-Sánchez, M.E. Icaza-Chávez, M.V. Bielsa-Fernández, et al.
Consenso mexicano sobre el síndrome de intestino irritable.
Rev Gastroenterol Mex, 81 (2016), pp. 149-167
[6]
G.J. Holtmann, A.C. Ford, N.J. Talley.
Pathophysiology of irritable bowel syndrome.
Lancet Gastroenterol Hepatol, 1 (2016), pp. 133-146
[7]
P.A. Hayes, M.H. Fraher, E.M.M. Quigley, et al.
Irritable bowel syndrome: the role of food in pathogenesis and management.
Gastroenterol Hepatol (N Y), 10 (2014), pp. 164-174
[8]
E.A. Williams, X.L. Nai, B.M. Corfe.
Dietary intakes in people with irritable bowel syndrome.
BMC Gastroenterol, 11 (2011), pp. 9
[9]
M. El-Salhy, H. Østgaard, D. Gundersen, et al.
The role of diet in the pathogenesis and management of irritable bowel syndrome (review).
Int J Mol Med, 29 (2012), pp. 723-731
[10]
D.A. Drossman, L. Chang, J. Kellow.
Rome IV: Functional Gastrointestinal Disorders: Disorders of Gut-Brain Interaction. Rome Foundation.
Gastroenterology, 6 (2016), pp. 1257-1261
[11]
Nutrimind. Nutrimind Software de Nutrición [Accessed 13 May 2024] Available in: https://www.nutrimind.net/page/software_de_nutricion.
[12]
Monash University. Monash University FODMAP Diet [Accessed 13 May 2024] Available in: https://www.monashfodmap.com/ibs-central/i-have-ibs/starting-the-low-fodmap-diet/.
[13]
H. Bourges, E. Casanueva, J.L. Rosado.
Recomendaciones de Ingestión de Nutrimentos para la población mexicana.
Médica Panamericana, 1 (2010), pp. 27-29
[14]
Federación Mexicana de Diabetes. Ingestión Diaria recomendada de sodio [Accessed 30 May 2024] Available from: https://fmdiabetes.org/que-es-el-sodio.
[15]
Y.A. Saito, G.R. Locke, A.L. Weaver, et al.
Diet and functional gastrointestinal disorders: A population-based case-control study.
Am J Gastroenterol, 100 (2005), pp. 2743-2748
[16]
Programa Nacional de Prevención de la Diabetes. Fase de seguimiento: Grasas: saturadas, insaturadas y trans ¿Qué es la grasa? CDC.
[17]
A. Cozma-Petrut, F. Loghin, D. Miere, et al.
Diet in irritable bowel syndrome: What to recommend, not what to forbid to patients!.
World J Gastroenterol, 23 (2017), pp. 3771-3783
[18]
B. Roth, E. Larsson, B. Ohlsson.
Poor intake of vitamins and minerals is associated with symptoms among patients with irritable bowel syndrome.
J Gastroenterol Hepatol, 37 (2022), pp. 1253-1262
[19]
S. Bek, Y.N. Teo, X.H. Tan, et al.
Association between irritable bowel syndrome and micronutrients: A systematic review.
J Gastroenterol Hepatol, 37 (2022), pp. 1485-1497
[20]
S. Espinosa-Salas, M. González-Arias.
Nutrition: Micronutrient Intake, Imbalances, and Interventions.
[21]
C. Dupont, G. Hébert.
Magnesium sulfate-rich natural mineral waters in the treatment of functional constipation–a review.
Nutrients, 12 (2020), pp. 2052
[22]
L. Zhang, Z. Du, Z. Li, et al.
Association of dietary magnesium intake with chronic constipation among US adults: Evidence from the National Health and Nutrition Examination Survey.
Food Sci Nutr, 9 (2021), pp. 6634-6641
[23]
S. Bek, Y.N. Teo, X.-H. Tan, et al.
Association between irritable bowel syndrome and micronutrients: A systematic review.
J Gastroenterol Hepatol, 37 (2022), pp. 1485-1497
[24]
L. Böhn, S. Störsrud, M. Simrén.
Nutrient intake in patients with irritable bowel syndrome compared with the general population.
Neurogastroenterol Motil, 25 (2013), pp. 23-31
[25]
M.J. Torres, J.-M. Sabate, M. Bouchoucha, et al.
Food consumption and dietary intakes in 36,448 adults and their association with irritable bowel syndrome: Nutrinet-Santé study.
Therap Adv Gastroenterol, 11 (2018),
[26]
J. Yang, M. Fox, Y. Cong, et al.
Lactose intolerance in irritable bowel syndrome patients with diarrhoea: the roles of anxiety, activation of the innate mucosal immune system and visceral sensitivity.
Aliment Pharmacol Ther, 39 (2014), pp. 302-311
[27]
M. Bellini, S. Tonarelli, A.G. Nagy, et al.
Low FODMAP Diet: Evidence, Doubts, and Hopes.
Nutrients, 12 (2020), pp. 148
[28]
Monash, University, High, low, FODMAP, foods.
A sample food list from the FODMAP experts.
[29]
J.J. Zhang, H. Ma, J.-Z. Zhu, et al.
The role of dietary energy and macronutrients intake in prevalence of irritable bowel syndromes.
Biomed Res Int, 2019 (2019),
[30]
Å Faresjö, S. Johansson, T. Faresjö, et al.
Sex differences in dietary coping with gastrointestinal symptoms.
Eur J Gastroenterol Hepatol, 22 (2010), pp. 327-333
Copyright © 2024. Asociación Mexicana de Gastroenterología
Download PDF
Idiomas
Revista de Gastroenterología de México
Article options
Tools
es en
Política de cookies Cookies policy
Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí. To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here.